Inflammatory Punctal Stenosis, Modalities, Treatment
Conditions
Brief summary
This study aimed to compare the efficacy of three various modalities of treatment of inflammatory punctal stenosis (Punctal dilatation alone, combined punctal dilatation with topical medications, or peri-punctal injection of Triamcinolone acetonide)
Detailed description
Acquired punctal stenosis is a condition in which the external opening of the lacrimal canaliculus, located in the nasal part of the palpebral margin, is narrowed or occluded. This condition results from chronic inflammation of the external punctum, leading to gradual fibrotic changes in the ostium, followed by progressive occlusion of the duct. Different modalities were described for the treatment of acquired punctual stenosis. Repeated dilatation of the stenotic punctum is a simple procedure that may provide temporary improvement of the symptoms, but restenosis is common unless additional procedures are performed. Many other methods were used to augment punctual size, including 1-snip, 2-snip, and 3-snip punctoplasty, supplemented with adding sutures or Mini-Monoka insertion and punch punctoplasty.
Interventions
PROCEDUREPunctal dilation
Patients were treated with punctal dilatation only.
DRUGPunctal dilation and topical medication
Patients were treated with a combination of punctal dilation and topical medication in the form of preservative-free steroid eye drops based on dexamethasone sodium phosphate (0.1%) and preservative-free artificial tears based on sodium hyaluronate, polyethylene, and propylene Glycol.
DRUGTriamcinolone acetonide
Patients were treated with a peri-punctual injection of Triamcinolone acetonide.
Sponsors
Tanta University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
33 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Age from 33 to 75. * Both sexes. * Patients with inflammatory punctal stenosis or occlusion complaining of symptomatic epiphora.
Exclusion criteria
* Subjects with previous lacrimal surgeries. * Subjects with lid margin malposition such as ectropion, entropion, or lid retraction. * Subjects with medial lid masses obscuring the punctum. * Subjects with a history of ocular trauma involving the medial aspect of the lid margin.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Degree of patient satisfaction | 3 months postoperatively | The degree of patient satisfaction was assessed using 3-point Likert Scale (1=Not satisfied, 2: No Difference, 3:Satisfied) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Punctal diameter | 3 months postoperatively | The punctal diameter of cases was measured before and after 1 month and 3 months of treatment. |
Countries
Egypt
Outcome results
None listed